RESUMO
Cerebral palsy (CP) is a common, clinically heterogeneous group of disorders affecting movement and posture. Its prevalence has changed little in 50 years and the causes remain largely unknown. The genetic contribution to CP causation has been predicted to be ~2%. We performed whole-exome sequencing of 183 cases with CP including both parents (98 cases) or one parent (67 cases) and 18 singleton cases (no parental DNA). We identified and validated 61 de novo protein-altering variants in 43 out of 98 (44%) case-parent trios. Initial prioritization of variants for causality was by mutation type, whether they were known or predicted to be deleterious and whether they occurred in known disease genes whose clinical spectrum overlaps CP. Further, prioritization used two multidimensional frameworks-the Residual Variation Intolerance Score and the Combined Annotation-dependent Depletion score. Ten de novo mutations in three previously identified disease genes (TUBA1A (n=2), SCN8A (n=1) and KDM5C (n=1)) and in six novel candidate CP genes (AGAP1, JHDM1D, MAST1, NAA35, RFX2 and WIPI2) were predicted to be potentially pathogenic for CP. In addition, we identified four predicted pathogenic, hemizygous variants on chromosome X in two known disease genes, L1CAM and PAK3, and in two novel candidate CP genes, CD99L2 and TENM1. In total, 14% of CP cases, by strict criteria, had a potentially disease-causing gene variant. Half were in novel genes. The genetic heterogeneity highlights the complexity of the genetic contribution to CP. Function and pathway studies are required to establish the causative role of these putative pathogenic CP genes.
Assuntos
Paralisia Cerebral/genética , Heterogeneidade Genética , Predisposição Genética para Doença/genética , Adulto , Animais , Estudos de Coortes , Exoma , Feminino , Biblioteca Gênica , Idade Gestacional , Humanos , Masculino , Mutação , Pais , Análise de Sequência de DNAAssuntos
Cromossomos Humanos X , Doenças Genéticas Ligadas ao Cromossomo X , Predisposição Genética para Doença/genética , Deficiência Intelectual/genética , Mutação/genética , Proteínas/genética , Proteínas de Transporte/metabolismo , Estudos de Casos e Controles , Estudos de Coortes , Proteínas de Ligação a DNA , Estudo de Associação Genômica Ampla , Humanos , Masculino , Proteínas Nucleares/metabolismo , Fenótipo , RNA Mensageiro/metabolismoRESUMO
The nonsense-mediated mRNA decay (NMD) pathway was originally discovered by virtue of its ability to rapidly degrade aberrant mRNAs with premature termination codons. More recently, it was shown that NMD also directly regulates subsets of normal transcripts, suggesting that NMD has roles in normal biological processes. Indeed, several NMD factors have been shown to regulate neurological events (for example, neurogenesis and synaptic plasticity) in numerous vertebrate species. In man, mutations in the NMD factor gene UPF3B, which disrupts a branch of the NMD pathway, cause various forms of intellectual disability (ID). Using Epstein Barr virus-immortalized B cells, also known as lymphoblastoid cell lines (LCLs), from ID patients that have loss-of-function mutations in UPF3B, we investigated the genome-wide consequences of compromised NMD and the role of NMD in neuronal development and function. We found that ~5% of the human transcriptome is impacted in UPF3B patients. The UPF3B paralog, UPF3A, is stabilized in all UPF3B patients, and partially compensates for the loss of UPF3B function. Interestingly, UPF3A protein, but not mRNA, was stabilised in a quantitative manner that inversely correlated with the severity of patients' phenotype. This suggested that the ability to stabilize the UPF3A protein is a crucial modifier of the neurological symptoms due to loss of UPF3B. We also identified ARHGAP24, which encodes a GTPase-activating protein, as a canonical target of NMD, and we provide evidence that deregulation of this gene inhibits axon and dendrite outgrowth and branching. Our results demonstrate that the UPF3B-dependent NMD pathway is a major regulator of the transcriptome and that its targets have important roles in neuronal cells.
Assuntos
Perfilação da Expressão Gênica/métodos , Deficiência Intelectual/genética , Degradação do RNAm Mediada por Códon sem Sentido/genética , Proteínas de Ligação a RNA/genética , Encéfalo/crescimento & desenvolvimento , Linhagem Celular , Linhagem Celular Transformada , Células Cultivadas , Proteínas Ativadoras de GTPase/genética , Expressão Gênica/genética , Hipocampo/anatomia & histologia , Hipocampo/crescimento & desenvolvimento , Humanos , Mutação , Neurônios/citologia , Proteínas de Ligação a RNA/metabolismo , Transdução de Sinais/genéticaRESUMO
Mutations in the UPF3B gene, which encodes a protein involved in nonsense-mediated mRNA decay, have recently been described in four families with specific (Lujan-Fryns and FG syndromes), nonspecific X-linked mental retardation (XLMR) and autism. To further elucidate the contribution of UPF3B to mental retardation (MR), we screened its coding sequence in 397 families collected by the EuroMRX consortium. We identified one nonsense mutation, c.1081C>T/p.Arg361(*), in a family with nonspecific MR (MRX62) and two amino-acid substitutions in two other, unrelated families with MR and/or autism (c.1136G>A/p.Arg379His and c.1103G>A/p.Arg368Gln). Functional studies using lymphoblastoid cell lines from affected patients revealed that c.1081C>T mutation resulted in UPF3B mRNA degradation and consequent absence of the UPF3B protein. We also studied the subcellular localization of the wild-type and mutated UPF3B proteins in mouse primary hippocampal neurons. We did not detect any obvious difference in the localization between the wild-type UPF3B and the proteins carrying the two missense changes identified. However, we show that UPF3B is widely expressed in neurons and also presents in dendritic spines, which are essential structures for proper neurotransmission and thus learning and memory processes. Our results demonstrate that in addition to Lujan-Fryns and FG syndromes, UPF3B protein truncation mutations can cause also nonspecific XLMR. We also identify comorbidity of MR and autism in another family with UPF3B mutation. The neuronal localization pattern of the UPF3B protein and its function in mRNA surveillance suggests a potential function in the regulation of the expression and degradation of various mRNAs present at the synapse.
Assuntos
Transtorno Autístico/genética , Códon sem Sentido/genética , Deficiência Intelectual/genética , Neurônios/metabolismo , Proteínas de Ligação a RNA/genética , Adulto , Substituição de Aminoácidos/genética , Animais , Transtorno Autístico/complicações , Linhagem Celular , Espinhas Dendríticas/metabolismo , Regulação para Baixo , Feminino , Hipocampo/metabolismo , Humanos , Deficiência Intelectual/complicações , Masculino , Camundongos , Pessoa de Meia-Idade , Linhagem , Estabilidade de RNA , Proteínas de Ligação a RNA/metabolismoRESUMO
Combined sewer overflows and stormwater discharges represent an important source of contamination to the environment. However, the harsh environment inside sewers and particular hydraulic conditions during rain events reduce the reliability of traditional flow measurement probes. In the following, we present and evaluate an in situ system for the monitoring of water flow in sewers based on video images. This paper focuses on the measurement of the water level based on image-processing techniques. The developed image-based water level algorithms identify the wall/water interface from sewer images and measure its position with respect to real world coordinates. A web-based user interface and a 3-tier system architecture enable the remote configuration of the cameras and the image-processing algorithms. Images acquired and processed by our system were found to reliably measure water levels and thereby to provide crucial information leading to better understand particular hydraulic behaviors. In terms of robustness and accuracy, the water level algorithm provided equal or better results compared to traditional water level probes in three different in situ configurations.
Assuntos
Inteligência Artificial , Drenagem Sanitária , Eliminação de Resíduos Líquidos/instrumentação , Processamento de Imagem Assistida por Computador/instrumentação , Processamento de Imagem Assistida por Computador/métodos , Fatores de Tempo , Eliminação de Resíduos Líquidos/métodosRESUMO
The goal of these studies was to examine the effects of substance P, a tachykinin neuropeptide, on pathways of microvascular permeability. Individual frog mesenteric venular capillaries were cannulated, and albumin apparent permeability coefficients (Ps) were determined by quantitative fluorescence microscopy. Ps of albumin (PsAlb) rose from 6.8 +/- 1.8 (SE) cm.s-1.10(7) at control to 22.3 +/- 2.3 cm.s-1.10(7) when substance P (10(-11) M) was perfused. The effect of increased microvessel permeability induced by substance P (10(-11) M) was blocked with the nonpeptide substance P receptor antagonist CP-96,345 and NG-nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide synthase. PsAlb increased 0.99 cm.s-1.10(7) for every cmH2O increase in microvessel pressure after treatment of the vessel with substance P, demonstrating coupling of albumin flux to transvascular water flow. In conclusion, the mechanism of increased microvessel permeability in response to substance P appears to be the result of receptor-mediated increase in nitric oxide production and formation of water-filled convective pathways presumably located between adjacent endothelial cells.
Assuntos
Permeabilidade Capilar/efeitos dos fármacos , Óxido Nítrico/fisiologia , Substância P/farmacologia , Aminoácido Oxirredutases/antagonistas & inibidores , Animais , Convecção , Difusão , Masculino , Microcirculação/efeitos dos fármacos , Óxido Nítrico Sintase , Rana pipiens , Receptores da Neurocinina-1/fisiologia , Albumina Sérica/farmacocinéticaRESUMO
Balloon mitral valvulotomy is used in treating mitral stenosis. We stabilized a near-moribund patient who had combined aortic and mitral valve stenoses with this technique on an emergency basis. Following valvulotomy, mitral valve area increased from 1.1 to 2.2 cm2, pulmonary capillary wedge pressure decreased from 31 to 21 mmHg, and cardiac index increased from 1.9 to 2.8 L/min/m2. When the patient's condition improved, we replaced the aortic and mitral valves with St. Jude Medical bileaflet prostheses. Balloon mitral valvulotomy has not been previously described as a "bridge" to operation. The patient in this report was at extremely high risk with cardiopulmonary and hepatorenal failure, and is the first where valvulotomy was used as temporary rather than definitive management. It should be considered only in cases without calcified, fibrotic valves and where the operative risk is considered prohibitive.